<DOC>
	<DOCNO>NCT02371499</DOCNO>
	<brief_summary>The aim study collect data assessment Lactobacillus casei DG ( Enterolactis plus® ) effect overall abdominal pain/discomfort , symptom gut microbiota composition patient Irritable Bowel Syndrome .</brief_summary>
	<brief_title>Effect Lactobacillus Casei DG ( Enterolactis Plus® ) Patient With Irritable Bowel Syndrome : Pilot Study</brief_title>
	<detailed_description>The aim study collect data assessment Lactobacillus casei DG ( Enterolactis plus® ) effect overall abdominal pain/discomfort , symptom gut microbiota composition patient Irritable Bowel Syndrome . The investigator suppose , due immunomodulatory action probiotic , overall abdominal pain/discomfort symptom improve , fecal Immunoglobulin A level change , pro-inflammatory cytokine level decrease production regulatory cytokine Interleukin 10 improve follow consumption Lactobacillus casei DG ( Enterolactis plus® ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Age &gt; 18 year ≤ 65 year . A positive diagnosis Irritable Bowel Syndrome regardless bowel habit ( male female ) , accord Rome III criterion . Negative outcome barium enema leave colonoscopy within previous two year . Negative relevant additional screening consultation whenever appropriate . Ability conform study protocol . Presence relevant organic , systemic metabolic disease ( particularly significant history cardiac , renal , neurological , psychiatric , oncology , endocrinology , metabolic hepatic disease ) , abnormal laboratory value deem clinically significant basis predefined value . Ascertained intestinal organic disease , include ascertain celiac disease inflammatory bowel disease ( Crohn 's disease , ulcerative colitis , diverticular disease , infectious colitis , ischemic colitis , microscopic colitis ) . Previous major abdominal surgery . Active malignancy type , history malignancy ( patient history malignancy surgically remove evidence recurrence least five year study enrolment also acceptable ) . Untreated food intolerance ascertain suspect lactose intolerance , define anamnestic evaluation , appropriate , lactose breath test . Assumption probiotic topic and/or systemic antibiotic therapy last month . Systematical/frequent assumption contact laxatives . Females childbearing potential , absence effective contraceptive method . Pregnant woman . Inability conform protocol . Treatment investigational drug within previous 30 day . Recent history suspicion alcohol abuse drug addiction . Previous participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Lactobacillus casei dg</keyword>
	<keyword>microbiota</keyword>
</DOC>